Mei Pharma Inc (MEIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2023 | 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,838 | -54,454 | -41,314 | -47,173 | -16,819 |
| Depreciation Amortization | 386 | 326 | 285 | 336 | 80 |
| Accounts payable and accrued liabilities | -1,784 | 1,563 | 3,918 | -2,350 | 1,144 |
| Other Working Capital | -24,947 | 16,875 | 16,942 | 51,424 | 8,386 |
| Other Operating Activity | 5,699 | -13,056 | -11,795 | 32,021 | -22,214 |
| Operating Cash Flow | $-52,484 | $-48,746 | $-31,964 | $34,258 | $-29,423 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 53,725 | 7,371 | 25,416 | -105,400 | 24,535 |
| PPE Investments | -35 | -479 | -708 | -894 | -217 |
| Investing Cash Flow | $53,690 | $6,892 | $24,708 | $-106,294 | $24,318 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 52,897 | 3,532 | 73,234 | 1,710 |
| Other Financing Activity | -40 | -3,846 | -64 | 1,543 | -324 |
| Financing Cash Flow | $-40 | $49,051 | $3,468 | $74,777 | $1,386 |
| Beginning Cash Position | 15,740 | 8,543 | 12,331 | 9,590 | 13,309 |
| End Cash Position | 16,906 | 15,740 | 8,543 | 12,331 | 9,590 |
| Net Cash Flow | $1,166 | $7,197 | $-3,788 | $2,741 | $-3,719 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,484 | -48,746 | -31,964 | 34,258 | -29,423 |
| Capital Expenditure | -35 | -479 | -708 | -894 | -217 |
| Free Cash Flow | -52,519 | -49,225 | -32,672 | 33,364 | -29,640 |